Vascular Innovations Webinars

We’re excited to announce Industry-led webinars, hosted by the SVS Foundation, that will convene leading experts to present the latest evidence, case-based discussions and real-world insights shaping vascular access and endovascular care.

Disclaimer: These webinars are the sole content of the Industry Sponsors and do NOT constitute an endorsement by the SVS or the SVS Foundation for any products, therapies, or speaker remarks. The speakers are selected by the Industry Sponsors, and their remarks are their own.

Upcoming Webinars

January 28, 2026 | 6 p.m. CST

Advancements in Arterial and Venous Obstructive Vascular Disease
Presented by Inari - now part of Stryker

Up to 10% of patients with chronic limb-threatening ischemia (CLTI) have no viable endovascular or surgical revascularization options, leaving them at high risk for major amputation. Transcatheter arterialization of the deep veins (TADV) with the purpose-built LimFlow System offers a novel limb-salvage approach by delivering oxygenated blood to the foot through the venous system. Early studies, including PROMISE I and the pivotal PROMISE II trial, have shown promising limb salvage and functional recovery. Building on this progress, the PROMISE III trial prospectively evaluates both clinical outcomes and the physiologic maturation of the TADV circuit. This webinar presents 6-month primary endpoint results, detailing hemodynamic changes, circuit maturation, and associated wound-healing patterns—offering new insight into the mechanism and expanding the role of LimFlow for no-option CLTI patients.

Past Webinars

Missed the webinars or want a replay? The full recordings are now available to watch on demand on SVS VascuLEARN.

November 12, 2025 - End Stage Kidney Disease & Vascular Access: “Innovation & Improved Fistula Outcomes" Presented by Laminate Medical

Program Highlights

Dr. Keith Ozaki will open with a discussion on the hemodynamic and mechanical factors driving fistula failure, their impact on outcomes, and how VasQ’s unique extravascular support mechanism addresses these challenges.
Dr. Ellen Dillavou will review the extensive clinical evidence behind VasQ, including insights from 15 peer-reviewed publications and her personal clinical experience with the device.
Dr. John Lucas will share his real-world perspective, focusing on basilic vein transpositions and how VasQ integration has improved patient outcomes in his ESKD practice.

What to Expect

30-minute presentation with expert-led discussions
15 minutes of Q&A to address your questions
Interactive participant survey

Discover how VasQ is reshaping fistula care and delivering meaningful results for patients with ESKD.

Speakers: Dr. Keith Ozaki, Dr. Ellen Dillavou, Dr. John Lucas

View the Recording

October 29, 2025 - From Data to Decisions: Optimizing Outcomes in PAD & CLI with Eluvia DES Presented by Boston Scientific

This session will highlight the latest clinical evidence on the Eluvia Drug-Eluting Stent (DES), including insights from the SPORTS RCT, Eluvia Pooled Meta-Analysis, and Eluvia TRUE-PTX data. Faculty experts will discuss how these findings reinforce Eluvia’s advantages over alternative modalities—particularly in treating long, challenging lesions.

Through case-based discussions and interactive dialogue, participants will gain practical strategies for integrating DES therapy into real-world practice and comparing its role to DCB and BMS approaches.

Key topics include:

Clinical data reinforcing Eluvia DES effectiveness
Case insights on long, complex lesions
DES vs. DCB/BMS in decision-making
Real-world outcomes: reduced amputations and re-hospitalizations
Impact on patient quality of life and hospital economics

Don’t miss this opportunity to deepen your knowledge and explore how DES therapy can improve outcomes for patients with PAD and CLI.

Speakers: Dr. Anahita Dua, Massachusetts General Hospital, Dr. Sonya Noor, Buffalo General Medical Center, and Dr. Peter Schneider University of California, San Francisco